World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
7876
World Ranking
4267
National Ranking
1942

Dirk M. Zajonc publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dirk M. Zajonc sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 227 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dirk M. Zajonc D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dirk M. Zajonc sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dirk M. Zajonc is affiliated with Pfizer in the United States and has contributed predominantly to the fields of immunology and microbiology. Their research spans various subfields including immunology, molecular biology, and spectroscopy, demonstrating a broad interdisciplinary approach within life sciences.

The scientist's work focuses on a range of topics related to immune cell function and interaction, T-cell and B-cell immunology, and immunotherapy and immune responses. Additional areas of interest include atherosclerosis and cardiovascular diseases, single-cell and spatial transcriptomics, receptor mechanisms and signaling, as well as mass spectrometry techniques and their applications.

Among the recent papers authored or coauthored by Dirk M. Zajonc are:

  • "Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications," 2023, published in Frontiers in Immunology
  • "Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation," 2020, published in International Journal of Molecular Sciences
  • "Single-cell transcriptomes and T cell receptors of vaccine-expanded apolipoprotein B-specific T cells," 2023, published in Frontiers in Cardiovascular Medicine
  • "Molecular Characterization of the Native (Non-Linked) CD160-HVEM Protein Complex Revealed by Initial Crystallographic Analysis," 2021, published in Crystals
  • "Molecular characterization of the native (non-linked) CD160-HVEM protein complex revealed by initial crystallographic analysis," 2021, published in Acta Crystallographica Section A Foundations and Advances

The scientist frequently publishes in venues such as Frontiers in Immunology, International Journal of Molecular Sciences, Frontiers in Cardiovascular Medicine, Crystals, and Acta Crystallographica Section A Foundations and Advances.

Collaborations form an essential aspect of Dirk M. Zajonc's research activities, with frequent coauthors including Simona Lenhartová, Marek Nemčovič, Radka Šebová, Mário Benko, and Ivana Nemčovičová. Each of these collaborators has worked with the scientist on multiple publications, indicating ongoing partnerships.

Best Publications

  • Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.

    Yuki Kinjo;Emmanuel Tupin;Douglass Wu;Masakazu Fujio

  • Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

    Yuki Kinjo;Petr Illarionov;José Luis Vela;Bo Pei

  • Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

    Dirk M Zajonc;Carlos Cantu;Jochen Mattner;Dapeng Zhou

  • T cell activation by lipopeptide antigens.

    D. Branch Moody;David C. Young;Tan-Yun Cheng;Jean-Pierre Rosat

  • Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A.

    Dirk M Zajonc;Marc A Elsliger;Luc Teyton;Ian A Wilson

  • The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides

    Lisa Kain;Bill Webb;Brian L. Anderson;Shenglou Deng

  • Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity

    Dirk M. Zajonc;Igor Maricic;Douglass Wu;Rarnesh Halder

  • Anatomy of CD1-lipid antigen complexes.

    D. Branch Moody;Dirk M. Zajonc;Ian A. Wilson

  • Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.

    Douglass Wu;Dirk M. Zajonc;Masakazu Fujio;Barbara A. Sullivan

  • Molecular Mechanism of Lipopeptide Presentation by CD1a

    Dirk M. Zajonc;M. D.Max Crispin;Thomas A. Bowden;David C. Young;David C. Young

  • Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14i NKT cells

    Barbara A. Sullivan;Niranjana A. Nagarajan;Gerhard Wingender;Jing Wang

  • Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies

    Shravan Madireddi;So-Young Eun;Seung-Woo Lee;Ivana Nemčovičová

  • Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.

    Enrico Girardi;Igor Maricic;Jing Wang;Thien-Thi Mac

  • Cardiolipin Binds to CD1d and Stimulates CD1d-Restricted γδ T Cells in the Normal Murine Repertoire

    Mélanie Dieudé;Harald Striegl;Aaron J. Tyznik;Jing Wang

  • Galactose‐modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis

    Sandrine Aspeslagh;Yali Li;Esther Dawen Yu;Nora Pauwels

  • Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

    Wendell Smith;Peter Tomasec;Rebecca Aicheler;Andrea Loewendorf

  • Crystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Vα14 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self Glycolipids

    Dirk M. Zajonc;Paul B. Savage;Albert Bendelac;Ian A. Wilson

  • Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.

    Jing Wang;Yali Li;Yuki Kinjo;Thien-Thi Mac

  • The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode

    Yali Li;Enrico Girardi;Jing Wang;Esther Dawen Yu

  • Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.

    Enrico Girardi;Dirk M. Zajonc

  • T-cell activation by lipopeptide antigens

    Ildiko Van Rhijn;Dirk M Zajonc;Ian A Wilson;D Branch Moody

Frequent Co-Authors

Ian A. Wilson
Ian A. Wilson Scripps Research Institute
Enrico Girardi
Enrico Girardi Austrian Academy of Sciences
Mitchell Kronenberg
Mitchell Kronenberg University of California, San Diego
D. Branch Moody
D. Branch Moody Brigham and Women's Hospital
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine
Bjoern Peters
Bjoern Peters La Jolla Institute For Allergy & Immunology
Luc Teyton
Luc Teyton Scripps Research Institute
Shane Crotty
Shane Crotty La Jolla Institute For Allergy & Immunology
Dirk Elewaut
Dirk Elewaut Ghent University
Gurdyal S. Besra
Gurdyal S. Besra University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Immunology in the USA, exploring related online degrees can broaden career opportunities in healthcare. Programs like top psychiatric mental health nurse practitioner programs online offer specialized training that complements immunological knowledge, preparing graduates for roles in mental health settings with strong clinical placement support.

Affordability is a key consideration when choosing a program. Accessing cheapest online pmhnp programs helps prospective students minimize educational costs while pursuing quality nurse practitioner education. This balance is crucial for managing investment and future earning potential.

Understanding the financial outlook is equally important. Data on how much do dnp nurses make provides valuable insights into salary expectations across the US, helping students assess the return on investment for advanced nursing degrees associated with immunology and patient care.

For those interested in acute patient care, information on acute care nurse practitioner programs outlines pathways to transition and further specialization. This can be an excellent option for immunology graduates focusing on critically ill patients requiring immune-related interventions.

Best Scientists Citing Dirk M. Zajonc

Trending Scientists